Authors: ZOPPO A MAGGI FM ZANCA R BAGGI L RUGGIO C CATAPANO AL

Citation: A. Zoppo et al., GEMFIBROZIL REDUCES PHOSPHOLIPID TRANSFER PROTEIN-ACTIVITY DURING THEPOSTPRANDIAL PHASE, Circulation, 94(8), 1996, pp. 1603-1603

Authors: CORSINI A MAGGI FM CATAPANO AL

Citation: A. Corsini et al., PHARMACOLOGY OF COMPETITIVE INHIBITORS OF HMG-COA REDUCTASE, Pharmacological research, 31(1), 1995, pp. 9-27

Authors: MAGGI FM PIGLIONICA MR DEMICHELE L BARONI S BIASI GM CATAPANO AL

Citation: Fm. Maggi et al., BEZAFIBRATE LOWERS ELEVATED PLASMA-LEVELS OF FIBRINOGEN AND LIPOPROTEIN(A) IN PATIENTS WITH TYPE-IIA AND TYPE-B DYSLIPOPROTEINEMIA, NMCD. Nutrition Metabolism and Cardiovascular Diseases, 4(4), 1994, pp. 215-220

Authors: MAGGI FM BERNINI F BARBERI L FANTONI M CATAPANO AL

Citation: Fm. Maggi et al., SIM-6080, A NEW CALCIUM-ANTAGONIST, REDUCES AORTIC ATHEROSCLEROSIS INCHOLESTEROL-FED RABBITS, Pharmacological research, 28(3), 1993, pp. 219-227

Authors: MAGGI FM BIASI GM CATAPANO AL

Citation: Fm. Maggi et al., REDUCTION OF LP(A) PLASMA-LEVELS BY BEZAFIBRATE, Atherosclerosis, 100(1), 1993, pp. 127-128